Journal List > J Korean Med Sci > v.37(16) > 1162102

TOOLS
Lim, Kim, Chung, Park, Kim, and Park: Association of Maternal Hypertensive Disorders During Pregnancy With Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis
Original Article
Pediatrics

Journal of Korean Medical Science 2022; 37(16): e127.

Published online: 18 April 2022

DOI: https://doi.org/10.3346/jkms.2022.37.e127

Association of Maternal Hypertensive Disorders During Pregnancy With Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis

Gina Lim1, Yoo Jinie Kim2, Sochung Chung2, 3, Yong Mean Park2, 3, Kyo Sun Kim2, Hye Won Park2, 3

1Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

2Department of Pediatrics, Konkuk University Medical Center, Seoul, Korea.

3Konkuk University School of Medicine, Seoul, Korea.

Address for Correspondence: Hye Won Park, MD. Department of Pediatrics, Konkuk University Medical Center, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea. 20110673@kuh.ac.kr

Received 3 December 2021       Accepted 25 March 2022

© 2022 The Korean Academy of Medical Sciences.

The Korean Academy of Medical Sciences

https://creativecommons.org/licenses/by-nc/4.0/
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

This meta-analysis was performed to examine the association between maternal hypertension during pregnancy (HDP) and neonatal bronchopulmonary dysplasia (BPD).

Methods

We systematically searched PubMed, EMBASE, the Cochrane Library, and the KoreaMed database for relevant studies. We used the Newcastle-Ottawa Scale for quality assessment of all included studies. The meta-analysis was performed using Comprehensive Meta-Analysis software (version 3.3).

Results

We included 35 studies that fulfilled the inclusion criteria; the total number of infants evaluated came to 97,399 through review process. Maternal HDP was not significantly associated with any definition of BPD, i.e., oxygen dependency at 36 weeks of gestation (odds ratio [OR], 1.162; 95% confidence interval [CI], 0.991–1.362; P = 0.064) in pooled analysis of 29 studies or oxygen dependency at 28 days of age (OR, 1.084; 95% CI, 0.660–1.780; P = 0.751) in pooled analysis of 8 studies. Maternal HDP was significantly associated only with severe BPD (OR, 2.341; 95% CI, 1.726–3.174; P < 0.001). BPD was not associated with HDP in the overall analysis (OR, 1.131; 95% CI, 0.977–1.309; P = 0.100) or subgroup analysis according to the definition of HDP.

Conclusion

Maternal HDP was not associated with neonatal BPD defined by the duration of oxygen dependency (at either 36 weeks of gestation or 28 days of life) but was associated with severe BPD.

Graphical Abstract

jkms-37-e127-abf001.jpg

Keywords: Bronchopulmonary Dysplasia, Hypertension, Pregnancy Induced, Infant, Newborn

INTRODUCTION

Bronchopulmonary dysplasia (BPD) is characterized by prolonged oxygen dependency or ventilator support of preterm infants.12 Various perinatal factors may affect BPD development, including lung damage and impaired alveolar and vascular development.123 Efforts have been made to predict the occurrence of BPD soon after birth4 and to prevent BPD in preterm infants using various ventilator strategies5 and the early caffeine use.6 However, the incidence of BPD has not decreased over the past 10 years in infants born at less than 30 weeks of gestation in Korea.7 Apart from postnatal care, prenatal management is important to prevent BPD. Hypertension during pregnancy (HDP) has been reported as a risk factor for BPD.89101112 HDP (including pre-eclampsia) causes various prenatal morbidities, including preterm birth, intra-uterine growth restriction, and maternal complications.1314 The placental pathology of HDP is characterized by placental insufficiency, decreased fetal perfusion, and intrauterine growth restriction; these are also risk factors for BPD.1516 We performed this meta-analysis to examine the association between maternal HDP and neonatal BPD in the preterm infants.

METHODS

Search strategy and study selection

We searched PubMed, EMBASE, the Cochrane Library, and the KoreaMed database for relevant studies. We used the following search terms: infant, premature, neonate, pregnancy-induced hypertension, pre-eclampsia, eclampsia, hypertension, BPD, and/or chronic lung disease. The last search was performed on June 18, 2019. The titles and abstracts of all articles were initially screened, and the full-text articles were then reviewed by two authors (Park HW and Lim G) using predefined selection criteria. We excluded case reports, case series, review articles, editorials, and comments. The reference lists of included studies were manually searched, as were other electronic databases. No language restriction was imposed; studies were translated if necessary.

Inclusion and exclusion criteria

We included randomized controlled trials, observational studies (cohort studies or case-control studies), and cross-sectional studies in the analysis. Single-arm cohort studies without comparison groups, case reports, case series and animal studies were excluded. Types of HDP included gestational hypertension, pre-eclampsia-eclampsia and pre-eclampsia superimposed on chronic hypertension (based on a report from the National High Blood Pressure Education Program Working Group14). The definition of elevated blood pressure (BP) varied among the studies, including systolic BP (sBP) ≥ 140 mmHg and/or diastolic BP (dBP) ≥ 90 mmHg,816171819202122232425262728293031323334353637 an increase in sBP ≥ 25 mmHg and/or dBP ≥ 15 mmHg29 and sBP ≥ 145 mmHg and/or dBP ≥ 95 mmHg3839 after week 20 of gestation. Pre-eclampsia was defined as sBP ≥ 160 mmHg and/or dBP ≥ 110 mmHg with proteinuria, an increased creatinine level, a decreased platelet count, elevated hepatic enzyme levels, cerebral or visual symptoms (including headache), or persistent epigastric pain.1440 The combination of hemolysis, elevated liver enzyme levels, and low platelet count was considered to indicate hemolysis, elevated liver enzymes, and a low platelet count (HELLP) syndrome. Eclampsia was defined as a combination of seizures and pre-eclampsia.14 Pre-eclampsia superimposed on chronic hypertension was defined as pre-eclampsia in women exhibiting chronic hypertension prior to pregnancy.14 The definition of BPD varied among studies; some16202224253137 used the National Institutes of Health consensus,41 while others defined BPD as either oxygen dependency 28 days postnatally184243 or at 36 weeks of postmenstrual age.81218212327282930323334353638394244454647

Data extraction and study quality assessment

Park HW and Lim G independently extracted data via full-text review of selected studies. We recorded first author names, year of publication, country of origin, study design, period, and population; definitions of HDP and BPD, sample size, and BPD rates in the HDP and non-HDP groups. We assessed study quality using the Newcastle-Ottawa Scale,48 which has three domains: selection (four items), comparability (one item), and outcomes (three items). All eight items are awarded one point, except comparability (two points). Total scores range from 0 to 9: 0–3 points reflect low quality, 4–5 points moderate quality, and ≥ 6 points high quality. Any discrepancy in quality scoring or data interpretation was resolved via discussion with a third reviewer (Park YM).

Data synthesis and statistical analysis

We meta-analyzed the relationship between maternal HPD and BPD using Comprehensive Meta-Analysis software (version 3.3; Biostat Inc., Englewood, NJ, USA). We used a random-effects model if heterogeneity was present and a fixed-effects model if heterogeneity was absent. We used the I2 statistic to evaluate statistical heterogeneity among studies. If I2 > 50%, significant between-study heterogeneity is present. We performed sensitivity analysis by removing each study individually from the analysis, and performed cumulative analyses to detect changes over time. We performed subgroup analyses according to the definition of pre-eclampsia. Funnel plot symmetry was assessed, and the Begg and Mazumdar rank correlation test and Egger regression test were performed to assess publication bias. We defined publication bias as funnel plot asymmetry or a P value < 0.05 in either the Begg and Mazumdar rank correlation test or Egger regression test. We also followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis checklist of 2009 (Supplementary Table 1).

RESULTS

Literature search and selection

A flowchart of the study inclusion/exclusion process is shown in Fig. 1. Of 1,056 studies obtained via database and manual searching, 336 duplicates were removed. Of the remaining 720 studies, 622 were excluded based on title or abstract review, and a further 63 during full text review. We finally included 35 studies.
Fig. 1

Flow diagram of study selection.

jkms-37-e127-g001

Characteristics of the included studies

The characteristics of the included studies are shown in Table 1.812161718192021222324252627282930313233343536373839424344454647495051 A total of 97,399 infants were included in the meta-analysis. Based on a BPD definition of oxygen requirement at 36 weeks of gestation, the incidence of BPD was 32.0% (3,768 of 12,445 cases) in the HDP group and 29.1% (18,101 of 62,152 cases) in the non-HDP group. Based on a BPD definition of oxygen requirement at 28 days of age, the incidence of BPD was 27.6% (205 of 640 cases) in the HDP group and 25.5% (444 of 1,743 cases) in the non-HDP group. The incidence of severe BPD was 25.4% (91 of 358 cases) in the HDP group and 14.3% (144 of 1,007 cases) in the non-HDP group. The incidence of undefined BPD was 9.0% (16 of 177 cases) in the HDP group and 25.8% (64 of 248 cases) in the non-HDP group.
Table 1

Characteristics of studies included in this meta-analysis

jkms-37-e127-i001
Studies Population Definition of HDP (after the 20th week of gestation) Definition of BPD (oxygen dependency) NOS
Spinillo et al.17 (1993) IUGR and/or preterm BP > 140/90 mmHg ± proteinuria NA 6
Kim et al.18 (1996) Bwt ≤ 1,250 g BP > 140/90 mmHg plus persistent proteinuria At 28 day PNA or 36 wk PMA 8
Todd et al.19 (1997) GA 24–32 wk Diastolic BP ≥ 90 mmHg At 36 wk of PMA 7
Korhonen et al.42 (1999) Bwt < 1,500 g NA At 28 day PNA and 36 wk PMA with radiologic changes 8
Redline et al.44 (2002) GA < 32 wk NA At 36 wk of PMA 6
Cunha et al.20 (2003) Bwt < 1,500 g BP > 140/90 mmHg NICHD workshop, 2001 6
Hernández-Ronquillo et al.43 (2004) Preterm NA At 28 PNA with radiologic changes 5
Akram Khan et al.21 (2006) GA < 30 wk BP > 140/90 mmHg plus proteinuria and nondependent edema At 36 wk of PMA and radiologic changes 7
Cetinkaya et al.22 (2010) GA < 37 wk BP > 140/90 mmHg plus proteinuria NICHD workshop, 2001 10
Hansen et al.8 (2010) GA 23–32 wk BP > 140/90 mmHg plus proteinuria At 36 wk of PMA 6
Schlapbach et al.23 (2010) GA 25–32 wk dBP > 90 mmHg plus proteinuria and/or acute spiral artery atherosis on placental histology At 36 wk of PMA 10
Gortner et al.45 (2011) GA 24–31 wk NA At 36 wk of PMA 6
O’Shea et al.12 (2012) GA < 28 wk or Bwt < 1,000 g Hypertension and proteinuria or nondependent edema At 36 wk of PMA 7
Ozkan et al.24 (2012) GA < 32 wk BP > 140/90 mmHg plus proteinuria NICHD workshop, 2001 5
Klinger et al.38 (2013) Bwt ≤ 1,500 g BP ≥ 145/95 mmHg plus proteinuria with/without proteinuria At 36 wk of PMA and clinical findings 6
Shima et al.25 (2013) GA < 32 wk BP > 140/90 mmHg NICHD workshop, 2001 7
Yen et al.26 (2013) Bwt < 1,500 g BP > 140/90 mmHg plus proteinuria At 36 wk of PMA 7
Morsing et al.27 (2014) GA < 30 wk dBP > 90 mmHg plus proteinuria NA 7
Çetinkaya46 (2015) GA ≤ 32 wk NA At 36 wk of PMA 10
Regev et al.39 (2015) GA 24–32 wk BP ≥ 145/95 mmHg At 36 wk of PMA and clinical & radiologic findings 7
Bwt ≤ 1,500 g
Gemmell et al.28 (2016) GA 24–28 wk BP > 140/90 mmHg At 36 wk of PMA 8
Matić et al.29 (2017) GA < 29 wk BP > 140/90 mmHg or rise in sBP ≥ 25 mmHg and/or dBP ≥ 15 mmHg At 36 wk of PMA 7
Morrow et al.49 (2017) GA ≤ 34 wk, Bwt 500–1,250 g NA NICHD workshop, 2001 6
Soliman et al.30 (2017) GA < 32 wk BP > 140/90 mmHg At 36 wk of PMA 6
Xu et al.50 (2017) Bwt < 1,500 g NA NA 7
Anwar et al.47 (2018) GA ≤ 32 wk NA At 36 wk of PMA 5
Kim et al.31 (2018) GA < 32 wk, singleton BP > 140/90 mmHg plus proteinuria NICHD workshop, 2001 7
Lu et al.32 (2018) GA < 34 wk BP > 140/90 mmHg At 36 wk of PMA or at discharge 6
Mao et al.51 (2018) GA 28–31 wk NA NICHD workshop, 2001 5
Razak et al.33 (2018) GA < 33 wk BP > 140/90 mmHg plus proteinuria At 36 wk of PMA 9
Rocha et al.34 (2018) GA 24–30 wk BP > 140/90 mmHg plus proteinuria At 36 wk of PMA 6
Strouss et al.16 (2018) Bwt < 1.500 g ACOG 2002 NICHD workshop, 2001 7
Yusuf et al.35 (2018) GA < 29 wk BP ≥ 140/90 mmHg At 36 wk of PMA 7
Tagliaferro et al.36 (2019) GA 23–28 wk BP > 140/90 mmHg plus proteinuria and/or thrombocytopenia, impaired liver function, pulmonary edema and new onset cerebral or visual disturbance At 36 wk of PMA 7
Wilmink et al.37 (2019) GA 24–31 wk BP ≥ 140/90 mmHg plus or maternal organ dysfunction or fetal growth restriction NICHD workshop, 2001 7
HDP = hypertension during pregnancy, BPD = bronchopulmonary dysplasia, NOS = The Newcastle-Ottawa Scale, IUGR = intrauterine growth restriction, BP = blood pressure, NA = not available, Bwt = birth weight, PNA = postnatal age, PMA = postmenstrual age, GA = gestational age at birth, NICHD = National Institute of Child Health and Human Development, dBP = diastolic blood pressure, sBP = systolic blood pressure, ACOG = American College of Obstetricians and Gynecologist.

Results of pooled meta-analysis

Of the 35 eligible studies, 29812161819212223242526282930313233343536373839444546474950 evaluated the relationship between HDP and BPD defined as an oxygen requirement at 36 weeks of gestation, and 81820242536374243 evaluated the relationship when BPD was defined as an oxygen requirement at 28 days of postnatal age. Two studies2436 evaluated the relationship between HDP and severe BPD, and three172750 the relationship between HDP and undefined BPD. Five studies1824253637 described one or more outcomes of BPD.
Regardless of the definition of hypertension, BPD was not associated with HDP in the overall analysis (odds ratio [OR], 1.131; 95% confidence interval [CI], 0.977–1.309; P = 0.100; Fig. 2). Subgroups were defined according to the definition of HDP: subgroup 1, pre-eclampsia and/or eclampsia and/or HELLP; subgroup 2, other HDP except chronic hypertension; subgroup 3, HDP including chronic hypertension. BPD was not associated with any HDP subgroup (Fig. 2).
Fig. 2

Meta-analysis of the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia: subgroup analysis based on the definition of HDP. Subgroups were defined according to the definition of HDP: subgroup 1, pre-eclampsia and/or eclampsia and/or HELLP; subgroup 2, other HDP except chronic hypertension; subgroup 3, HDP including chronic hypertension.

HDP = hypertension during pregnancy, HELLP = hemolysis, elevated liver enzymes, and a low platelet count, CI = confidence interval.
jkms-37-e127-g002
Maternal HDP was not significantly associated with BPD defined as an oxygen dependency at 36 weeks of gestation (OR, 1.162; 95% CI, 0.991–1.362; P = 0.064; Fig. 3). In the meta-analysis of the relationship between maternal HDP and BPD based on oxygen dependency at 36 weeks of gestation, significant between-study heterogeneity was evident (P < 0.001; I2 = 86.07%) so a random-effects model was used. The Begg and Mazumdar rank correlation test (P = 0.302), Egger regression test (P = 0.494) and funnel plot (Supplementary Fig. 1) showed no evidence of publication bias. The data did not change when each study was sequentially removed or added (Supplementary Fig. 2).
Fig. 3

Meta-analysis of the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 36 weeks of gestational age.

HDP = hypertension during pregnancy,, CI = confidence interval.
jkms-37-e127-g003
Maternal HDP was not significantly associated with BPD defined as oxygen dependency at 28 days of age (OR, 1.084; 95% CI, 0.660–1.780; P = 0.751; Fig. 4). In the meta-analysis of the relationship between maternal HDP and BPD defined as oxygen dependency at 28 days of age, significant heterogeneity was evident among the studies (P < 0.001; I2 = 78.92%) so a random-effects model was used. Both the Begg and Mazumdar rank correlation test (P = 0.035) and Egger regression test (P = 0.011) revealed evidence of publication bias. Thus, we performed trim and fill adjustments and the results did not change (OR, 1.084; 95% CI, 0.660–1.780) (Supplementary Fig. 3). No changes were seen in the sensitivity (Supplementary Fig. 4A) or cumulative (Supplementary Fig. 4B) analysis.
Fig. 4

Meta-analysis of the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 28 days of postnatal age.

HDP = hypertension during pregnancy, CI = confidence interval.
jkms-37-e127-g004
Maternal HDP was significantly associated with severe BPD (OR, 2.341; 95% CI, 1.726–3.174; P < 0.001; Fig. 5). There was no significant between-study heterogeneity (P = 0.963; I2 = 0%) so a fixed-effects model was used. Publication bias could not be evaluated because of the small number of studies. Sensitivity and cumulative analyses revealed no significant changes.
Fig. 5

Meta-analysis of the relationship between maternal pre-eclampsia and severe bronchopulmonary dysplasia.

HDP = hypertension during pregnancy, HELLP = hemolysis, elevated liver enzymes and low platelet, CI = confidence interval.
jkms-37-e127-g005

DISCUSSION

The incidence of HDP is 2–8%.91314 HDP can cause maternal and fetal complications including preterm birth, intrauterine growth restriction, and fetal death.13 Early onset (before 33 weeks of gestation) and severe disease are associated with increased risks of maternal and perinatal morbidity.1314 HDP includes gestational hypertension, pre-eclampsia/eclampsia, pre-eclampsia superimposed on chronic hypertension, and chronic hypertension.5253 Pre-eclampsia is defined by the American College of Obstetricians and Gynecologists as hypertension with proteinuria, or new-onset thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, or cerebral or visual symptoms.53 Among the 35 studies included in this meta-analysis, 10 did not define HDP.22384243444749505154 HDP was diagnosed based on BP and proteinuria in 15 studies81216182122232426273133343637 and on the basis of BP only in 10.171920252829303539
BPD is a chronic lung disease requiring oxygen or ventilator support; many antenatal and postnatal factors, and preterm birth, affect BPD development.12 Pre-eclampsia, one of several antenatal factors, is characterized by impaired lung alveolar and vascular development.255 Changes in the levels of several anti-angiogenic and angiogenic factors have been reported in women with pre-eclampsia.815315657585960 Angiogenic factors affect fetal lung development (especially pulmonary vascular growth and alveolarization) in animal models.565961 It has been suggested that increased levels of anti-angiogenetic factors and/or inhibition of the angiogenic pathway in women with pre-eclampsia could inhibit fetal vascular or alveolar lung development56; this is the “new BPD” described by Jobe1 and Abman.62 However, the strength of the relationship between HDP and BPD varied among previous reports.8266364 The BPD risk of infants born to mothers with pre-eclampsia was elevated (unadjusted OR, 1.29; adjusted OR, 1.59) in the studies of Hansen et al.8 and Bi et al.9 (unadjusted OR, 2.96; adjusted OR, 18.7). On the contrary, HDP reduced the risk of BPD in the study of Yen et al.26 and had no association with BPD of preterm infants in other reports.122223 Although HDP overall was associated with BPD in the study of Bi et al.,9 pre-eclampsia was not and pre-eclampsia/HELLP (pooled result) was only marginally associated with BPD in the unadjusted model. We found that maternal HDP was not significantly associated with BPD defined as an oxygen dependency at either 36 weeks of gestation (OR, 1.162; 95% CI, 0.991–1.362; P = 0.064; Fig. 3) or 28 days of age (OR, 1.132; 95% CI, 0.743–1.724; P = 0.563; Fig. 4), unlike previous studies.89 Moreover, the incidence of BPD and duration of mechanical ventilation did not differ between the pre-eclampsia and non-pre-eclampsia groups in the study of Shin et al.65 It is possible that we found no association between HDP and BPD (other than severe BPD) because the clinical definitions of BPD were inconsistent. The risk of BPP in the HDP group without fetal growth restriction did not differ from that of the group without HDP, and maternal HDP was associated with BPD in cases exhibiting antenatal fetal growth restriction.10 Dravet-Gounot et al.11 explored the association between fetal growth restriction and BPD in neonates born to mothers with pre-eclampsia. Pre-eclampsia onset before 34+0 weeks of gestation (early onset), which causes fetal growth restriction, constituted only 5–20% of all pre-eclampsia cases, most of which were late-onset and thus did not cause fetal growth restriction or changes in umbilical artery blood flow.66 As early onset pre-eclampsia increases the risk of neonatal morbidity, pre-eclampsia during a critical phase of development and/or the prolonged actions of anti-angiogenetic and/or angiogenic factors may be associated with BPD.1314 We assume that continued and severe pre-eclampsia causing fetal growth restriction compromises lung development and causes BPD.
We found that maternal HDP was significantly associated only with severe BPD (OR, 2.341; 95% CI, 1.726–3.174; P < 0.001; Fig. 5). Bi et al.9 reported an association between HDP severity and BPD but the duration of ventilator support and oxygen administration are likely to vary by clinician and medical unit66; mild-to-moderate BPD does not reflect lung status. However, severe BPD always requires respiratory assistance or high concentrations of oxygen. BPD can be diagnosed without additional testing based on the physiologic definition of BPD if an infant requires over 30% oxygen or positive pressure ventilation (invasive or non-invasive).66 Severe BPD has been further subclassified based on the need for invasive mechanical ventilation (or not).67 Clinically, type 2 severe BPD is defined as a need for invasive mechanical ventilation, and is associated with poorer outcomes (including death, pulmonary hypertension, and neurodevelopmental impairment) than is type 1 BPD (defined as a need for oxygen or non-invasive mechanical support68).
Our work had certain limitations. First, data on the time of HDP onset were unavailable, and we did not evaluate the associations of changes in the levels of anti-angiogenic and angiogenic factors with HDP or neonatal BPD. It was inevitable because of limitations of a meta-analysis based on only the results of previously reported studies. Second, this meta-analysis showed an association between maternal HDP and severe BPD. However, only a small number of studies have described the BPD severity. Additional clinical studies are needed to verify the relationship between maternal HDP and severe BPD.
In conclusion, we found no association between maternal HDP and neonatal BPD, other than severe BPD. Further studies should evaluate the relationships of HDP onset and/or changes in the levels of HDP-associated anti-angiogenetic and angiogenic factors with neonatal BPD.

Notes

Disclosure: The authors have no potential conflicts of interest to disclose.

Author Contributions:

  • Conceptualization: Park HW.

  • Data curation: Lim G, Kim YJ, Park HW.

  • Formal analysis: Lim G, Kim YJ, Park HW.

  • Investigation: Lim G, Kim YJ.

  • Methodology: Lim G, Kim YJ, Park HW.

  • Supervision: Chung S, Park YM, Kim KS, Park HW.

  • Writing - original draft: Lim G.

  • Writing - review & editing: Kim YJ, Chung S, Park YM, Kim KS, Park HW.

References

1. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999; 46(6):641–643. PMID: 10590017.
2. Mandell EW, Abman SH. Fetal vascular origins of bronchopulmonary dysplasia. J Pediatr. 2017; 185:7–10.e1. PMID: 28359535.
3. Abman SH. Bronchopulmonary dysplasia: “a vascular hypothesis”. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1755–1756. PMID: 11734417.
4. Shim SY, Yun JY, Cho SJ, Kim MH, Park EA. The prediction of bronchopulmonary dysplasia in very low birth weight infants through clinical indicators within 1 hour of delivery. J Korean Med Sci. 2021; 36(11):e81. PMID: 33754511.
5. Sung TJ. Bronchopulmonary dysplasia: How can we improve its outcomes? Korean J Pediatr. 2019; 62(10):367–373. PMID: 31122011.
6. Park HW, Lim G, Chung SH, Chung S, Kim KS, Kim SN. Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis. J Korean Med Sci. 2015; 30(12):1828–1835. PMID: 26713059.
7. Jeon GW. Changes in the incidence of bronchopulmonary dysplasia among preterm infants in a single center over 10 years. Neonatal Med. 2020; 27(1):1–7.
8. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr. 2010; 156(4):532–536. PMID: 20004912.
9. Bi GL, Chen FL, Huang WM. The association between hypertensive disorders in pregnancy and bronchopulmonary dysplasia: a systematic review. World J Pediatr. 2013; 9(4):300–306. PMID: 24235063.
10. Torchin H, Ancel PY, Goffinet F, Hascoët J-M, Truffert P, Tran D, et al. Placental complications and bronchopulmonary dysplasia: EPIPAGE-2 cohort study. Pediatrics. 2016; 137(3):e20152163. PMID: 26908662.
11. Dravet-Gounot P, Torchin H, Goffinet F, Aubelle MS, El Ayoubi M, Lefevre C, et al. Bronchopulmonary dysplasia in neonates born to mothers with preeclampsia: impact of small for gestational age. PLoS One. 2018; 13(9):e0204498. PMID: 30248159.
12. O’Shea JE, Davis PG, Doyle LW. Victorian Infant Collaborative Study Group. Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants. Pediatr Res. 2012; 71(2):210–214. PMID: 22258134.
13. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365(9461):785–799. PMID: 15733721.
14. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000; 183(1):S1–22.
15. Mestan KK, Gotteiner N, Porta N, Grobman W, Su EJ, Ernst LM. Cord blood biomarkers of placental maternal vascular underperfusion predict bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr. 2017; 185:33–41. PMID: 28162769.
16. Strouss L, Goldstein ND, Locke R, Paul DA. Vascular placental pathology and the relationship between hypertensive disorders of pregnancy and neonatal outcomes in very low birth weight infants. J Perinatol. 2018; 38(4):324–331. PMID: 29311628.
17. Spinillo A, Stronati M, Ometto A, Fazzi E, Lanzi G, Guaschino S. Infant neurodevelopmental outcome in pregnancies complicated by gestational hypertension and intra-uterine growth retardation. J Perinat Med. 1993; 21(3):195–203. PMID: 8229610.
18. Kim CR, Vohr BR, Oh W. Effects of maternal hypertension in very-low-birth-weight infants. Arch Pediatr Adolesc Med. 1996; 150(7):686–691. PMID: 8673191.
19. Todd DA, Jana A, John E. Chronic oxygen dependency in infants born at 24-32 weeks’ gestation: the role of antenatal and neonatal factors. J Paediatr Child Health. 1997; 33(5):402–407. PMID: 9401883.
20. Cunha GS, Mezzacappa Filho F, Ribeiro JD. Maternal and neonatal factors affecting the incidence of bronchopulmonary dysplasia in very low birth weight newborns. J Pediatr (Rio J). 2003; 79(6):550–556. PMID: 14685454.
21. Akram Khan M, Kuzma-O’Reilly B, Brodsky NL, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol. 2006; 26(7):428–435. PMID: 16724120.
22. Cetinkaya M, Ozkan H, Köksal N, Karali Z, Ozgür T. Neonatal outcomes of premature infants born to preeclamptic mothers. J Matern Fetal Neonatal Med. 2010; 23(5):425–430. PMID: 19670043.
23. Schlapbach LJ, Ersch J, Adams M, Bernet V, Bucher HU, Latal B. Impact of chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm infants below 32 weeks gestational age. Acta Paediatr. 2010; 99(10):1504–1509. PMID: 20456275.
24. Ozkan H, Cetinkaya M, Koksal N. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med. 2012; 25(12):2681–2685. PMID: 22759075.
25. Shima Y, Kumasaka S, Migita M. Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease. Pediatr Int. 2013; 55(5):578–581. PMID: 23745727.
26. Yen TA, Yang HI, Hsieh WS, Chou HC, Chen CY, Tsou KI, et al. Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study. PLoS One. 2013; 8(9):e75168. PMID: 24073247.
27. Morsing E, Maršál K. Pre-eclampsia- an additional risk factor for cognitive impairment at school age after intrauterine growth restriction and very preterm birth. Early Hum Dev. 2014; 90(2):99–101. PMID: 24388669.
28. Gemmell L, Martin L, Murphy KE, Modi N, Håkansson S, Reichman B, et al. Hypertensive disorders of pregnancy and outcomes of preterm infants of 24 to 28 weeks’ gestation. J Perinatol. 2016; 36(12):1067–1072. PMID: 27583388.
29. Matić M, Inati V, Abdel-Latif ME, Kent AL. NSW ACT NICUS Network. Maternal hypertensive disorders are associated with increased use of respiratory support but not chronic lung disease or poorer neurodevelopmental outcomes in preterm neonates at <29 weeks of gestation. J Paediatr Child Health. 2017; 53(4):391–398. PMID: 28121046.
30. Soliman N, Chaput K, Alshaikh B, Yusuf K. Preeclampsia and the risk of bronchopulmonary dysplasia in preterm infants less than 32 weeks’ gestation. Am J Perinatol. 2017; 34(6):585–592. PMID: 27919118.
31. Kim DH, Shin SH, Kim EK, Kim HS. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia. Pregnancy Hypertens. 2018; 13:148–153. PMID: 30177044.
32. Lu CQ, Lin J, Yuan L, Zhou JG, Liang K, Zhong QH, et al. Pregnancy induced hypertension and outcomes in early and moderate preterm infants. Pregnancy Hypertens. 2018; 14:68–71. PMID: 30527121.
33. Razak A, Patel W, Durrani N, McDonald SD, Vanniyasingam T, Thabane L, et al. Neonatal respiratory outcomes in pregnancy induced hypertension: introducing a novel index. J Matern Fetal Neonatal Med. 2020; 33(4):625–663. PMID: 30157682.
34. Rocha G, de Lima FF, Machado AP, Guimarães H. Collaborators of the Hypertensive Disorders of Pregnancy Study Group. Preeclampsia predicts higher incidence of bronchopulmonary dysplasia. J Perinatol. 2018; 38(9):1165–1173. PMID: 29808003.
35. Yusuf K, Alshaikh B, da Silva O, Lodha AK, Wilson RD, Alvaro RE, et al. Neonatal outcomes of extremely preterm infants exposed to maternal hypertension and cigarette smoking. J Perinatol. 2018; 38(8):1051–1059. PMID: 29740191.
36. Tagliaferro T, Jain D, Vanbuskirk S, Bancalari E, Claure N. Maternal preeclampsia and respiratory outcomes in extremely premature infants. Pediatr Res. 2019; 85(5):693–696. PMID: 30770862.
37. Wilmink FA, Reijnierse J, Reiss IK, Steegers EA, de Jonge RC. Research Consortium Neonatology South-West of the Netherlands. Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates. Pregnancy Hypertens. 2019; 15:57–63. PMID: 30825928.
38. Klinger G, Sokolover N, Boyko V, Sirota L, Lerner-Geva L, Reichman B, et al. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol. 2013; 208(2):115.e1–115.e9. PMID: 23178245.
39. Regev RH, Arnon S, Litmanovitz I, Bauer-Rusek S, Boyko V, Lerner-Geva L, et al. Outcome of singleton preterm small for gestational age infants born to mothers with pregnancy-induced hypertension. A population-based study. J Matern Fetal Neonatal Med. 2015; 28(6):666–673. PMID: 24871570.
40. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988; 158(4):892–898. PMID: 3364501.
41. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163(7):1723–1729. PMID: 11401896.
42. Korhonen P, Tammela O, Koivisto AM, Laippala P, Ikonen S. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev. 1999; 54(3):245–258. PMID: 10321791.
43. Hernández-Ronquillo L, Téllez-Zenteno JF, Weder-Cisneros N, Salinas-Ramírez V, Zapata-Pallagi JA, da Silva O. Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res. 2004; 35(6):549–553. PMID: 15631883.
44. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res. 2002; 52(5):713–719. PMID: 12409518.
45. Gortner L, Misselwitz B, Milligan D, Zeitlin J, Kollée L, Boerch K, et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology. 2011; 99(2):112–117. PMID: 20733331.
46. Çetinkaya M, Çekmez F, Erener-Ercan T, Buyukkale G, Demirhan A, Aydemir G, et al. Maternal/neonatal vitamin D deficiency: a risk factor for bronchopulmonary dysplasia in preterms? J Perinatol. 2015; 35(10):813–817. PMID: 26226242.
47. Anwar M, Ismat S, Qamber JH, Bano M. Bronchopulmonary dysplasia: a hazard factor in preterms due to maternal/neonatal vitamin D inadequacy. Pak J Med Health Sci. 2018; 12(3):1291–1295.
48. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed July 19, 2019. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .
49. Morrow LA, Wagner BD, Ingram DA, Poindexter BB, Schibler K, Cotten CM, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017; 196(3):364–374. PMID: 28249118.
50. Xu SZ, Hu XY, Zhao F, Zhou YX, Zhang SC. Effect of pregnancy-induced hypertension syndrome on complications in very low birth weight preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2017; 19(4):402–404. PMID: 28407825.
51. Mao X, Qiu J, Zhao L, Xu J, Yin J, Yang Y, et al. Vitamin D and IL-10 deficiency in preterm neonates with bronchopulmonary dysplasia. Front Pediatr. 2018; 6:246. PMID: 30246004.
52. Mammaro A, Carrara S, Cavaliere A, Ermito S, Dinatale A, Pappalardo EM, et al. Hypertensive disorders of pregnancy. J Prenat Med. 2009; 3(1):1–5. PMID: 22439030.
53. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013; 122(5):1122–1131. PMID: 24150027.
54. Gortner L, Wauer RR, Stock GJ, Reiter HL, Reiss I, Jorch G, et al. Neonatal outcome in small for gestational age infants: do they really better? J Perinat Med. 1999; 27(6):484–489. PMID: 10732308.
55. Jobe A. The new BPD. Neoreviews. 2006; 7(10):e531–e545.
56. Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012; 302(1):L36–L46. PMID: 22003089.
57. Tsao PN, Su YN, Li H, Huang PH, Chien CT, Lai YL, et al. Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema. Am J Respir Crit Care Med. 2004; 169(4):505–511. PMID: 14644931.
58. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1971–1980. PMID: 11734454.
59. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000; 279(3):L600–L607. PMID: 10956636.
60. Leaños-Miranda A, Navarro-Romero CS, Sillas-Pardo LJ, Ramírez-Valenzuela KL, Isordia-Salas I, Jiménez-Trejo LM. Soluble endoglin as a marker for preeclampsia, its severity, and the occurrence of adverse outcomes. Hypertension. 2019; 74(4):991–997. PMID: 31446801.
61. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002; 283(3):L555–L562. PMID: 12169575.
62. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am. 1994; 41(2):277–315. PMID: 8139877.
63. Palta M, Gabbert D, Weinstein MR, Peters ME. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. The Newborn Lung Project. J Pediatr. 1991; 119(2):285–292. PMID: 1861218.
64. Hakulinen A, Heinonen K, Jokela V, Kiekara O. Occurrence, predictive factors and associated morbidity of bronchopulmonary dysplasia in a preterm birth cohort. J Perinat Med. 1988; 16(5-6):437–446. PMID: 3241290.
65. Shin SH, Shin SH, Kim SH, Kim YJ, Cho H, Kim EK, et al. The association of pregnancy-induced hypertension with bronchopulmonary dysplasia - a retrospective study based on the Korean Neonatal Network database. Sci Rep. 2020; 10(1):5600. PMID: 32221404.
66. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004; 114(5):1305–1311. PMID: 15520112.
67. Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017; 181:12–28.e1. PMID: 27908648.
68. Kim HR, Jung YH, Kim BI, Kim SY, Choi CW. Differences in comorbidities and clinical burden of severe bronchopulmonary dysplasia based on disease severity. Front Pediatr. 2021; 9:664033. PMID: 34277516.

SUPPLEMENTARY MATERIALS

Supplementary Table 1

The Preferred Reporting Items for Systematic Reviews and Meta-Analysis 2009 checklist
jkms-37-e127-s001.doc

Supplementary Fig. 1

Funnel plot for the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 36 weeks of gestation.
jkms-37-e127-s002.doc

Supplementary Fig. 2

Sensitivity analysis (A) and cumulative analysis (B) for the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 36 weeks of gestation.
jkms-37-e127-s003.doc

Supplementary Fig. 3

Funnel plot the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 28 days of age. An asymmetrical funnel plot indicated possible publication bias, thus, we performed a trim and fill adjustment.
jkms-37-e127-s004.doc

Supplementary Fig. 4

Sensitivity analysis (A) and cumulative analysis (B) for the relationship between maternal pre-eclampsia and neonatal bronchopulmonary dysplasia defined as an oxygen requirement at 28 days of age.
jkms-37-e127-s005.doc
TOOLS
Similar articles